Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure (2022)
- Authors:
- Autor USP: BACHEGA, TÂNIA APARECIDA SARTORI SANCHEZ - FM
- Unidade: FM
- DOI: 10.1530/EJE-21-1085
- Subjects: CRIANÇAS; ADOLESCENTES; HIPERTENSÃO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: European journal of endocrinology
- ISSN: 0804-4643
- Volume/Número/Paginação/Ano: v. 186, n. 5, p. 587-596, 2022
- Status:
- Artigo aberto em periódico híbrido (Hybrid Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
NEUMANN, Uta et al. Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure. European journal of endocrinology, v. 186, n. 5, p. 587-596, 2022Tradução . . Disponível em: https://doi.org/10.1530/EJE-21-1085. Acesso em: 11 abr. 2026. -
APA
Neumann, U., Linde, A. van der, Krone, R. E., Krone, N. P., Guven, A., Guran, T., et al. (2022). Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure. European journal of endocrinology, 186( 5), 587-596. doi:10.1530/EJE-21-1085 -
NLM
Neumann U, Linde A van der, Krone RE, Krone NP, Guven A, Guran T, Elsedfy H, Poyrazoglu S, Darendeliler F, Bachega TASS. Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure [Internet]. European journal of endocrinology. 2022 ; 186( 5): 587-596.[citado 2026 abr. 11 ] Available from: https://doi.org/10.1530/EJE-21-1085 -
Vancouver
Neumann U, Linde A van der, Krone RE, Krone NP, Guven A, Guran T, Elsedfy H, Poyrazoglu S, Darendeliler F, Bachega TASS. Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure [Internet]. European journal of endocrinology. 2022 ; 186( 5): 587-596.[citado 2026 abr. 11 ] Available from: https://doi.org/10.1530/EJE-21-1085 - Effects of endocrine disruptors in the development of the female reproductive tract
- Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry
- Molecular -genetic causes underlying primary adrenal insufficiency. [Editorial]: current insights into diagnosis and treatment
- Os interferentes endócrinos ambientais precisam receber a atenção dos endocrinologistas brasileiros [Carta]
- High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening
- Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency
- Hiperplasia congênita das supras-renais
- Hiperplasia adrenal congênita
- The Actual Incidence of Congenital Adrenal Hyperplasia in Brazil May Not be as High as Inferred - An Estimate Based on a Public Neonatal Screening Program in the State of Goiás
- Hiperplasia adrenal congênita
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
